Clinical Evidence for the Choice of the Direct Oral Anticoagulant in Patients with Atrial Fibrillation According to Creatinine Clearance

• Những tác giả chính: Riccardo Vio (Tác giả), Riccardo Proietti (Tác giả), Matteo Rigato (Tác giả), Lorenzo Arcangelo Calò (Tác giả)
• Định dạng: Sách
• Được phát hành: MDPI AG, 2021-03-01T00:00:00Z.
• Những chủ đề: article
• Truy cập trực tuyến: Connect to this object online.

Atrial fibrillation (AF) often coexists with chronic kidney disease (CKD), which confer to the patient a higher risk of both thromboembolic and hemorrhagic events. Oral anticoagulation therapy, nowadays preferably with direct oral anticoagulants (DOACs), represents the cornerstone for ischemic strok...